FDA’s marketing denials for Myblu ‘very ominous news’ for US vaping industry

The company that makes the Myblu vaping pod has a 30-day window to challenge the US Food and Drug Administration (FDA)’s denial of premarket tobacco applications (PMTAs) for the device and flavoured refills.

The 30-day deadline for a legal challenge began from the date of the marketing denial orders for the Myblu device kit and six flavours, including Intense Tobacco, Intense Tobacco Chill and Gold Leaf. It is the first such denial issued by the FDA in six months, and American Vaping Association (AVA) president Gregory Conley said it “looks like very ominous news”.


Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Email us